Literature DB >> 21271268

Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods.

G Valenza1, S Müller, C Schmitt, D Turnwald, T-T Lam, M Frosch, M Abele-Horn, Y Pfeifer.   

Abstract

The VITEK 2 AST-N111 card was evaluated for detection of extended-spectrum beta-lactamases (ESBLs) by testing 51 ESBL positive and 50 ESBL negative isolates of E. coli, K. pneumoniae, and K. oxytoca. The occurrence of beta-lactamase genes was confirmed by PCR and sequencing. The advanced expert system (AES) of the VITEK 2 system achieved sensitivity and specificity values of 100% and 96.0%, respectively. The ESBL test of the VITEK 2 AST-N111 card showed a sensitivity of 92.1% and a specificity of 90.0%. Contradictory results obtained with the two VITEK 2 tools could be clarified by combination disk tests in nine of 11 isolates. The combined use of AES and ESBL tests of the AST-N111 card in association with combination disk tests in case of contradictory results seems to be a reliable method for ESBL detection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21271268     DOI: 10.1007/s10096-011-1169-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  False-positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 beta-lactamase.

Authors:  Nicola A C Potz; Melissa Colman; Marina Warner; Rosy Reynolds; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-02-12       Impact factor: 5.790

2.  High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.

Authors:  L B Rice; L L Carias; A M Hujer; M Bonafede; R Hutton; C Hoyen; R A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.

Authors:  Irith Wiegand; Heinrich K Geiss; Dietrich Mack; Enno Stürenburg; Harald Seifert
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

Review 4.  Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.

Authors:  R Cantón; A Novais; A Valverde; E Machado; L Peixe; F Baquero; T M Coque
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

5.  Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases.

Authors:  F Robin; J Delmas; C Schweitzer; R Bonnet
Journal:  Clin Microbiol Infect       Date:  2007-12-10       Impact factor: 8.067

6.  Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.

Authors:  J Färber; K-A Moder; F Layer; I Tammer; W König; B König
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

7.  Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae.

Authors:  Spyros Pournaras; Aggeliki Poulou; Evangelia Voulgari; Georgia Vrioni; Ioulia Kristo; Athanassios Tsakris
Journal:  J Antimicrob Chemother       Date:  2010-06-03       Impact factor: 5.790

Review 8.  Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.

Authors:  L Drieux; F Brossier; W Sougakoff; V Jarlier
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

9.  Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.

Authors:  Dolunay Gülmez; Neil Woodford; Marie-France I Palepou; Shazad Mushtaq; Gokhan Metan; Yusuf Yakupogullari; Sesin Kocagoz; Omrum Uzun; Gulsen Hascelik; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2008-03-12       Impact factor: 5.283

10.  Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.

Authors:  Sabine Gröbner; Dirk Linke; Wolfgang Schütz; Claudia Fladerer; Johannes Madlung; Ingo B Autenrieth; Wolfgang Witte; Yvonne Pfeifer
Journal:  J Med Microbiol       Date:  2009-06-05       Impact factor: 2.472

View more
  2 in total

1.  The accuracy of extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella pneumoniae in South African laboratories using the Vitek 2 Gram-negative susceptibility card AST-N255.

Authors:  Andrea L Young; Mark P Nicol; Clinton Moodley; Colleen M Bamford
Journal:  S Afr J Infect Dis       Date:  2019-08-07

2.  Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes?

Authors:  Pranita D Tamma; Virginia M Pierce; Sara E Cosgrove; Ebbing Lautenbach; Anthony Harris; Divya Rayapati; Jennifer H Han
Journal:  Open Forum Infect Dis       Date:  2018-06-08       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.